ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,401,332 | -43.6% | 8,322,140 | 0.0% | 0.24% | -33.9% |
Q2 2023 | $20,222,800 | -52.9% | 8,322,140 | +11.7% | 0.37% | -56.5% |
Q1 2023 | $42,895,526 | -35.6% | 7,447,140 | 0.0% | 0.84% | -33.9% |
Q4 2022 | $66,577,432 | -37.1% | 7,447,140 | 0.0% | 1.27% | -35.2% |
Q3 2022 | $105,898,000 | -2.6% | 7,447,140 | -0.0% | 1.97% | -0.2% |
Q2 2022 | $108,728,000 | -26.9% | 7,447,141 | 0.0% | 1.97% | -18.3% |
Q1 2022 | $148,719,000 | +14.2% | 7,447,141 | 0.0% | 2.41% | +44.0% |
Q4 2021 | $130,250,000 | +129.7% | 7,447,141 | +3.0% | 1.67% | +168.7% |
Q3 2021 | $56,706,000 | -23.8% | 7,232,856 | 0.0% | 0.62% | -17.3% |
Q2 2021 | $74,426,000 | -21.3% | 7,232,856 | 0.0% | 0.75% | -14.9% |
Q1 2021 | $94,606,000 | +0.4% | 7,232,856 | +7.8% | 0.88% | +7.3% |
Q4 2020 | $94,255,000 | +18.2% | 6,708,507 | 0.0% | 0.82% | -17.7% |
Q3 2020 | $79,764,000 | – | 6,708,507 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 558,636 | $3,217,743 | 2.38% |
TANG CAPITAL MANAGEMENT LLC | 2,520,000 | $14,515,200 | 2.16% |
COWEN AND COMPANY, LLC | 3,143,608 | $18,107,182 | 2.13% |
DAFNA Capital Management LLC | 797,054 | $4,591,031 | 1.38% |
JOHNSON & JOHNSON | 728,944 | $4,198,717 | 1.37% |
Decheng Capital Management III (Cayman), LLC | 580,000 | $3,340,800 | 1.35% |
Orbimed Advisors | 7,447,140 | $42,895,526 | 0.84% |
EcoR1 Capital, LLC | 3,560,700 | $20,509,632 | 0.66% |
Granite Point Capital Management, L.P. | 65,729 | $378,599 | 0.52% |
RTW INVESTMENTS, LP | 4,241,472 | $24,430,879 | 0.51% |